Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Iran’S Research Prioritization: Are We Meeting the Goals? a Study Based on Clinical Trial Registry Data Publisher Pubmed



Fakhri F1 ; Mohammadi M2 ; Eybpoosh S3 ; Ahmadi S4 ; Solaymanidodaran M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Cell and Molecular Biology, School of Advanced Sciences, Medical Branch, Islamic Azad University, Tehran, Iran
  3. 3. Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran
  4. 4. Student Research Committee, Nursing and Midwifery School, Kermanshah University of Medical Sciences, Kermanshah, Iran
  5. 5. Minimally Invasive Surgery Research Center, Hazrat-e-Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran

Source: PLoS ONE Published:2024


Abstract

The prioritization of research topics in the health domain is a critical step toward channelling efforts and resources into areas that have received less attention. The objective of this study is to evaluate the implementation of research priorities determined at the national level within Iran for the period spanning five years between 2009 and 2013. We extracted the required data from the Iranian Registry of Clinical Trials (IRCT) website. Then we conducted a matching process between the titles of trials registered in the IRCT until December 3rd, 2013, and the list of national health research priorities in the domains of communicable and non-communicable diseases. The latter was compiled and regulated by the Research and Technology Deputy of the Ministry of Health since 2008. Out of the total 5,049 clinical trials registered in IRCT, 92.3% were carried out within the domain of non-communicable diseases, while 6.1% pertained to the field of communicable diseases and the remaining 1.3% in other fields. 56.4% of the clinical trials conducted in the field of communicable diseases and 32.8% of those conducted in the field of non-communicable diseases were consistent with the research priorities determined in these two fields. During the five-year period of the prioritization goal, there was no significant improvement in adherence to the list of priorities compared to the previous five-year period. Furthermore, certain priorities were neglected within both areas during these periods. It is possible to evaluate the effectiveness of research prioritization using the data obtained from the registration centers of clinical trials. Our study has revealed that the list of priorities has not garnered adequate attention from the research community within the country. Hence, remedial measures are imperative to ensure the priorities are given more attention after publication. © 2024 Public Library of Science. All rights reserved.
Related Docs
1. Characteristics of Clinical Trials in Iran: A Sample of 5000 Trials Registered in Irct, Iranian Journal of Epidemiology (2019)
2. Comparative Assessment of a Covid-19 Vaccine After Technology Transfer to Iran From Critical Quality Attributes to Clinical and Immunogenicity Aspects, Scientific Reports (2024)
3. Immunogenicity and Safety of Heterologous Boost Immunization With Pastocovac Plus Against Covid-19 in Chadox1-S or Bbibp-Corv Primed Individuals, PLoS Pathogens (2023)
4. Priority-Setting in Health Research in Iran: A Qualitative Study on Barriers and Facilitators, Health Research Policy and Systems (2018)
5. Evaluation of Pastocovac Plus Vaccine As a Booster Dose on Vaccinated Individuals With Inactivated Covid-19 Vaccine, Heliyon (2023)
Experts (# of related papers)
View all Related Experts
Alireza Biglari (3)
Arash Rashidian (1)